Clinical Trials in Portland

Showing 6881-6900 of 10,048 trials

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

NCT01675661

The primary objective of this study is to evaluate the impact of N-acetylcysteine (NAC) 1200 mg versus matched placebo (PBO) twice daily, added to contingency management (CM), on cannabis use among treatment-seeking cannabis-dependent adults (ages 18-50).

Cannabis Dependence

Medical University of South Carolina302 participantsStarted Jan 2014

Los Angeles, California, United States • New Haven, Connecticut, United States • Lexington, Kentucky, United States +3 more locations

COMPLETEDNA< 1 mile

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

NCT00417989

Primary Outcomes: Average decrease in A1c from baseline to end of Study Phase (52 weeks) for subjects in the "722 Group" is greater than that for subjects in the "Control (MDI) Group". Secondary Outcomes: Incidence and frequency of severe hypoglycemia; Measure of glycemic variability, Area Under the Curve (AUC); Quality of Life; and Health Economic Outcomes (MRU)

Type 1 Diabetes

Medtronic Diabetes485 participantsStarted Jan 2007

La Jolla, California, United States • Orange, California, United States • Boulder, Colorado, United States +27 more locations

Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

Find Trials by Condition in Portland

A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus Vaccine

Vascular Inflammation in Psoriasis - Extension Study

Vascular Inflammation in Psoriasis Trial (The VIP Trial)

Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia

A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

Single Agent Ofatumumab Vs. Single Agent Rituximab in Indolent B-Cell Non Hodgkin Lymphoma Relapsed After Rituximab-Containing Therapy

Phase 1 and 2 Study of PX-866 and Cetuximab

Phase 1 Study of ONT-10 in Patients With Solid Tumors

A Study in Participants With Rheumatoid Arthritis

PF-00489791 For The Treatment Of Raynaud's

Thrombolysis in Pediatric Stroke (TIPS)

Study of the Safety, and Sperm and Gonadotropin Suppression of a Contraceptive Gel in Normal Men

Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer

Radiosurgery or Open Surgery for Epilepsy Trial

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers

Prospective Multicenter Registry On RadiaTion Dose Estimates Of Cardiac CT AngIOgraphy IN Daily Practice in 2017

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)